Pharmaceutical Technology3h
Adcendo raises $135m as ADC funding frenzy continues
Founded in 2017 as a spin-out from the University of Copenhagen and Rigshospitalet, Adcendo previously raised $102.8m (€98m) ...
Pharmaceutical Technology4h
Sustainability in biopharma: Collaboration and technology light the way forward
The biopharmaceutical industry is being called to take its sustainability efforts to the next level. A new report sheds light ...
Pharmaceutical Technology5h
GSK gains approval in Japan for extended indication of RSV vaccine
GSK has received approval from Japan's MHLW for its application to extend the indication of its RSV vaccine, Arexvy.
Pharmaceutical Technology9h
MSD’s WELIREG approved by NMPA to treat VHL disease-associated tumours
China’s NMPA has approved MSD’s WELIREG (belzutifan) to treat adult individuals with certain types of VHL disease-associated ...
Pharmaceutical Technology8h
GSK eyes up combo approval for previously withdrawn myeloma drug
The US Food and Drug Administration (FDA) is expected to make a Prescription Drug User Fee Act (PDUFA) decision by mid-2025.
Pharmaceutical Technology10h
Exploring drug shortages in european markets: the causes, analysis, and response
Since 2023, the pharmaceutical industry operating in Europe has faced an unprecedented challenge related to drug shortages.
Pharmaceutical Technology11h
FDA approves BridgeBio’s Attruby for ATTR-CM treatment
The US Food and Drug Administration (FDA) has approved BridgeBio Pharma ’s Attruby (acoramidis), an oral transthyretin (TTR) ...
Pharmaceutical Technology7h
Trump’s presidency return: boom or bust for biopharmaceutical deal activity?
On 5 November 2024, former US president Donald Trump was elected to a second term in the US presidential election.